Weak start to FY2025-26, tough times ahead
12/02/26 -"CZM reported weak Q1 results, with challenges in both ophthalmology and microsurgery. Profitability declined significantly due to FX headwinds, an unfavourable product mix, and increased amortisation ..."
Pages
60
Language
English
Published on
12/02/26
You may also be interested by these reports :
12/02/26
CZM reported weak Q1 results, with challenges in both ophthalmology and microsurgery. Profitability declined significantly due to FX headwinds, an ...
11/02/26
4Q sales increased 12.1% YoY (18.4% at constant currency) to €7.6bn, mainly driven by strong growth in AI glasses. However, this category continues ...
10/02/26
Philips’ Q4 results exceeded expectations, with comparable sales growth driven by strong performance in Personal Health and healthy contributions ...
06/02/26
Coloplast delivered a weak Q1, with both revenue and adjusted EBIT missing consensus. Organic growth of 6% was in line with expectations, but ...